A randomized, double-blind, placebo-controlled trial of long-acting risperidone in cocaine-dependent men

Journal of Clinical Psychiatry

Volumn 69, Issue 3, 2008, Pages 480-486

  Loebl, Tsafrir ^a   Angarita, Gustavo A ^a,b   Pachas, Gladys N ^a   Huang, Kai Lin ^a,c   Lee, Sang H ^a   Nino, Johanna ^a   Logvinenko, Tanya ^a   Culhane, Melissa A ^a   Evins, A Eden ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HAMILTON SCALE; HUMAN; INCREASED APPETITE; LIBIDO; MALE; MUSCLE RIGIDITY; MUSCLE TWITCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SIDE EFFECT; SOMNOLENCE; TARDIVE DYSKINESIA; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

EID: 42249089868     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0321     Document Type: Article

References (34)

1. Substance Abuse and Mental Health Services Administration. Results from the 2003 National Survey on Drug Use and Health: National Findings. Rockville, Md: US Dept Health Human Services, Office of Applied Studies, NSDUH Series H-25; 2004. DHHS publication SMA 04-3964
2. Drug Abuse Warning Network, 2005: National Estimates of Drug-Related Emergency Department Visits. Rockville, Md: US Dept Health Human Services, DAWN Series D-29; March 2007. DHHS Publication SMA 07-4256
3. Volkow ND, Wang GJ, Fischman MW, et al. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 1997;386(6627):827-830
4. Self DW, Barnhart WJ, Lehman DA, et al. Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science 1996;271(5255):1586-1589
5. Weissenborn R, Deroche V, Koob GF, et al. Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine-associated stimulus. Psychopharmacology (Berl) 1996;126(4):311-322
6. Khroyan TV, Barrett-Larimore RL, Rowlett JK, et al. Dopamine D1-and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists. J Pharmacol Exp Ther 2000; 294(2):680-687
7. Tsibulsky VL, Grocki S, Dashevsky BA, et al. Mixed D2/5-HT2A antagonism of cocaine-induced facilitation of brain stimulation reward. Pharmacol Biochem Behav 1998;59(2):275-280
8. Broderick PA, Rahni DN, Zhou Y. Acute and subacute effects of risperidone and cocaine on accumbens dopamine and serotonin release using in vivo microvoltammetry on line with open-field behavior. Prog Neuropsychopharmacol Biol Psychiatry 2003 Sep;27(6):1037-1054
9. Newton TF, Ling W, Kalechstein AD, et al. Risperidone pre-treatment reduces the euphoric effects of experimentally administered cocaine. Psychiatry Res 2001;102(3):227-233
10. De La Garza R II, Newton TF, Kalechstein AD. Risperidone diminishes cocaine-induced craving. Psychopharmacology (Berl) 2005 Mar; 178(2-3):347-350
11. Grabowski J, Rhoades H, Silverman P, et al. Risperidone for the treatment of cocaine dependence: randomized, double-blind trial. J Clin Psychopharmacol 2000;20(3):305-310
12. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, Version 2.0). New York, NY: Biometrics Research, New York State Psychiatric Institute; 1995
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
14. Kilts CD, Gross RE, Ely TD, et al. The neural correlates of cue-induced craving in cocaine-dependent women. Am J Psychiatry 2004 Feb;161(2); 233-241
15. Pettinati HM, Weiss RD, Miller W, et al. COMBINE Monograph Series, Vol. 2. Medical Management Treatment Manual: a Clinical Research Guide for Medically Trained Clinicians Providing Pharmacotherapy as Part of the Treatment for Alcohol Dependence. Bethesda, Md: US Dept Health Human Services, National Institute on Alcohol Abuse and Alcoholism; 2004. DHHS publication NIH 04-5289
16. Halikas JA, Kuhn KL, Crosby R, et al. The measurement of craving in cocaine patients using the Minnesota Cocaine Craving Scale. Compr Psychiatry 1991;32(1):22-27
17. Kampman KM, Volpicelli JR, McGinnis DE, et al. Reliability and validity of the Cocaine Selective Severity Assessment. Addict Behav 1998;23(4):449-461
18. Levine J, Schooler NR. SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull 1986;22(2):343-381
19. McLellan AT, Kushner H, Metzger D, et al. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat 1992;9(3):199-213
20. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
21. Snaith RP, Hamilton M, Morley S, et al. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry 1995;167(1):99-103
22. Faustman WO, Faull KF, Whiteford HA, et al. CSF 5-HIAA, serum cortisol, and age differentially predict vegetative and cognitive symptoms in depression. Biol Psychiatry 1990;27(3):311-318
23. Levin FR, McDowell D, Evans SM, et al. Pergolide mesylate for cocaine abuse: a controlled preliminary trial. Am J Addict 1999;8(2):120-127
24. Grabowski J, Rhoades H, Stotts A, et al. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 2004;29(5):969-981
25. Gorelick DA, Gardner EL, Xi ZX. Agents in development for the management of cocaine abuse. Drugs 2004;64(14):1547-1573
26. Smelson DA, Williams J, Ziedonis D, et al. A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients. J Subst Abuse Treat 2004;27(1):45-49
27. Smelson DA, Losonczy MF, Davis CW, et al. Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. Can J Psychiatry 2002;47(7):671-675
28. Smelson DA, Roy A, Roy M. Risperidone diminishes cue-elicited craving in withdrawn cocaine-dependent patients [letter]. Can J Psychiatry 1997 Nov;42(9):984
29. Volkow ND, Wang GJ, Fowler JS, et al. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997;386(6627):830-833
30. Krakowski M, Czobor P, Volavka J. Effect of neuroleptic treatment on depressive symptoms in acute schizophrenic episodes. Psychiatry Res 1997;71(1):19-26
31. Nasrallah H. A review of the effect of atypical antipsychotics on weight. Psychoneuroendocrinology 2003 Jan;28(suppl 1):83-96
32. Ciraulo DA, Sarid-Segal O, Knapp CM, et al. Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence. Addiction 2005 Mar;100(suppl 1):12-22
33. Jones RT. Pharmacokinetics of cocaine: considerations when assessing cocaine use by urinalysis. NIDA Res Monogr 1997;175:221-234
34. Kiev A. Management of clinical trials with new medications for cocaine dependence and abuse. NIDA Res Monogr 1997;175:96-117